ENSG00000078579


Homo sapiens

Features
Gene ID: ENSG00000078579
  
Biological name :FGF20
  
Synonyms : FGF20 / fibroblast growth factor 20 / Q9NP95
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 8
Strand: -1
Band: p22
Gene start: 16992169
Gene end: 17002181
  
Corresponding Affymetrix probe sets: 220394_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000180166
Ensembl peptide - ENSP00000428072
NCBI entrez gene - 26281     See in Manteia.
OMIM - 605558
RefSeq - NM_019851
RefSeq Peptide - NP_062825
swissprot - Q9NP95
swissprot - H0YAT9
Ensembl - ENSG00000078579
  
Related genetic diseases (OMIM): 615721 - ?Renal hypodysplasia/aplasia 2, 615721
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 fgf20aENSDARG00000007356Danio rerio
 fgf20bENSDARG00000086070Danio rerio
 FGF20ENSGALG00000013663Gallus gallus
 Fgf20ENSMUSG00000031603Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
FGF9 / P31371 / fibroblast growth factor 9ENSG0000010267870
FGF16 / O43320 / fibroblast growth factor 16ENSG0000019646863
FGF3 / P11487 / fibroblast growth factor 3ENSG0000018689537
FGF5 / P12034 / fibroblast growth factor 5ENSG0000013867534
FGF4 / P08620 / fibroblast growth factor 4ENSG0000007538833
FGF13 / Q92913 / fibroblast growth factor 13ENSG0000012968232
FGF10 / O15520 / fibroblast growth factor 10ENSG0000007019332
FGF7 / P21781 / fibroblast growth factor 7ENSG0000014028532
FGF22 / Q9HCT0 / fibroblast growth factor 22ENSG0000007038832
FGF14 / Q92915 / fibroblast growth factor 14ENSG0000010246630
FGF6 / P10767 / fibroblast growth factor 6ENSG0000011124130
FGF11 / Q92914 / fibroblast growth factor 11ENSG0000016195830
FGF12 / P61328 / fibroblast growth factor 12ENSG0000011427928


Protein motifs (from Interpro)
Interpro ID Name
 IPR002209  Fibroblast growth factor family
 IPR008996  Cytokine IL1/FGF
 IPR028291  Fibroblast growth factor 20


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0000165 MAPK cascade TAS
 biological_processGO:0007165 signal transduction TAS
 biological_processGO:0007267 cell-cell signaling TAS
 biological_processGO:0008284 positive regulation of cell proliferation IEA
 biological_processGO:0008543 fibroblast growth factor receptor signaling pathway IEA
 biological_processGO:0010469 regulation of signaling receptor activity IEA
 biological_processGO:0014059 regulation of dopamine secretion TAS
 biological_processGO:0018108 peptidyl-tyrosine phosphorylation IEA
 biological_processGO:0030154 cell differentiation IEA
 biological_processGO:0036092 phosphatidylinositol-3-phosphate biosynthetic process IEA
 biological_processGO:0043524 negative regulation of neuron apoptotic process IDA
 biological_processGO:0045664 regulation of neuron differentiation IEA
 biological_processGO:0046854 phosphatidylinositol phosphorylation IEA
 biological_processGO:0051897 positive regulation of protein kinase B signaling TAS
 biological_processGO:0060043 regulation of cardiac muscle cell proliferation IEA
 biological_processGO:0060113 inner ear receptor cell differentiation IEA
 biological_processGO:0065009 regulation of molecular function IEA
 biological_processGO:0070374 positive regulation of ERK1 and ERK2 cascade IEA
 biological_processGO:1904340 positive regulation of dopaminergic neuron differentiation TAS
 cellular_componentGO:0005576 extracellular region IEA
 cellular_componentGO:0005622 intracellular IEA
 molecular_functionGO:0004713 protein tyrosine kinase activity TAS
 molecular_functionGO:0005088 Ras guanyl-nucleotide exchange factor activity TAS
 molecular_functionGO:0005102 signaling receptor binding TAS
 molecular_functionGO:0005104 fibroblast growth factor receptor binding IEA
 molecular_functionGO:0008083 growth factor activity IEA
 molecular_functionGO:0016303 1-phosphatidylinositol-3-kinase activity TAS
 molecular_functionGO:0043395 heparan sulfate proteoglycan binding TAS
 molecular_functionGO:0046934 phosphatidylinositol-4,5-bisphosphate 3-kinase activity TAS
 molecular_functionGO:0090722 receptor-receptor interaction IDA


Pathways (from Reactome)
Pathway description
PI3K Cascade
PIP3 activates AKT signaling
Signaling by activated point mutants of FGFR1
Signaling by activated point mutants of FGFR3
FGFR4 ligand binding and activation
FGFR3b ligand binding and activation
FGFR3c ligand binding and activation
FGFR1c ligand binding and activation
FGFR2c ligand binding and activation
FGFR3 mutant receptor activation
Activated point mutants of FGFR2
Constitutive Signaling by Aberrant PI3K in Cancer
Phospholipase C-mediated cascade: FGFR1
Phospholipase C-mediated cascade; FGFR2
Phospholipase C-mediated cascade; FGFR3
Phospholipase C-mediated cascade; FGFR4
Downstream signaling of activated FGFR1
SHC-mediated cascade:FGFR1
PI-3K cascade:FGFR1
FRS-mediated FGFR1 signaling
PI-3K cascade:FGFR2
SHC-mediated cascade:FGFR2
FRS-mediated FGFR2 signaling
SHC-mediated cascade:FGFR3
FRS-mediated FGFR3 signaling
PI-3K cascade:FGFR3
FRS-mediated FGFR4 signaling
SHC-mediated cascade:FGFR4
PI-3K cascade:FGFR4
Negative regulation of FGFR1 signaling
Negative regulation of FGFR2 signaling
Negative regulation of FGFR3 signaling
Negative regulation of FGFR4 signaling
Signaling by FGFR2 in disease
Signaling by FGFR1 in disease
RAF/MAP kinase cascade
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
Signaling by FGFR3 point mutants in cancer


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000008 Abnormality of female internal genitalia 
Show

 HP:0000104 Renal agenesis 
Show

 HP:0000175 Cleft palate "Cleft palate is a developmental defect of the `palate` (FMA:54549) resulting from a failure of fusion of the palatine processes." [HPO:curators]
Show

 HP:0000286 Epicanthus "An epicanthal fold is a semilunar fold of skin that extends from the upper eyelid across the medial canthal area to the lower eyelid." [HPO:curators]
Show

 HP:0000316 Hypertelorism 
Show

 HP:0000369 Low-set ears "Low-set ears are defined to be set below an arbitrary line drawn between the lateral canthus of the eye and the occipital protruberance." [HPO:curators]
Show

 HP:0000457 Flat nose 
Show

 HP:0001562 Oligohydramnios 
Show

 HP:0001563 Fetal polyuria 
Show

 HP:0001582 Loose, redundant skin 
Show

 HP:0001958 Nonketotic hypoglycemia 
Show

 HP:0002009 Potter facies 
Show

 HP:0002089 Pulmonary hypoplasia 
Show

 HP:0002242 Abnormality of the intestines 
Show

 HP:0002575 Tracheoesophageal fistula "An abnormal connection (fistula) between the esophagus and the trachea." [HPO:curators]
Show

 HP:0005107 Abnormality of the sacrum 
Show

 HP:0010497 Sirenomelia "A developmental defect in which the legs are fused together." [HPO:curators]
Show

 HP:0030680 Abnormality of cardiovascular system morphology "Any structural anomaly of the heart and great vessels." []
Show

 HP:0100335 Non-midline cleft lip 
Show

 HP:0100589 Urogenital fistula "The presence of a `fistula` (MPATH:70) affecting the `genitourinary system` (FMA:280610)." [HPO:probinson]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
No match






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr